Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Sarcoma: Page 5
Inivata touts liquid biopsy studies
By
LabPulse.com staff writers
The ability of the test of circulating tumor DNA (ctDNA) to detect genetic mutations was evaluated in 264 patients with nonsquamous non-small cell lung cancer (NSCLC) in two multicenter studies. Results were published by Dr. Michael Pritchett and colleagues in the journal on April 25, following their presentation at the World Conference on Lung Cancer in September 2018.
April 25, 2019
Epic Sciences gets CE Mark for liquid biopsy kit
By
LabPulse.com staff writers
The kit is compatible with Epic's offerings of diagnostic and clinical trial tests, including tests designed for interventional use. The liquid biopsy collection kit is designed to stabilize and preserve blood samples for shipping to sites operated by Epic Sciences around the world.
April 23, 2019
Liquid biopsy results help TARGET cancer treatments in U.K. study
By
Emily Hayes
In an ideal world, all cancer patients would get a personalized treatment regimen based on the molecular profile of their particular tumor. But tissue biopsies are invasive, and results may become outdated over time as cancers evolve.
April 22, 2019
Journal eyes liquid biopsy's promise with special edition
By
LabPulse.com staff writers
Liquid biopsy detects markers for disease in bodily fluids less invasively than tissue biopsy. This makes it easier for physicians to monitor cancer progression in patients and to adjust treatment regimens as cancer cells develop resistance to existing therapies.
April 21, 2019
Liquid biopsy tracks response to lung cancer treatment
By
Brian Casey
The results suggest that noninvasive tests using blood samples have the potential to change cancer therapy by evaluating treatment response more quickly, helping patients avoid treatments that are toxic or ineffective, according to Dr. Victor Velculescu, PhD, co-director of cancer biology at the Johns Hopkins Kimmel Cancer Center.
February 12, 2019
Previous Page
Page 5 of 5